# Palmitoylethanolamide for Chronic Inflammatory Pain Conditions

> **NCT06273462** · PHASE2 · RECRUITING · sponsor: **Navy Medical Center San Diego** · enrollment: 80 (estimated)

## Conditions studied

- Chronic Pain

## Interventions

- **DRUG:** Palmitoylethanolamide 600mg twice a day
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT06273462
- **Lead sponsor:** Navy Medical Center San Diego
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-05
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-10-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06273462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06273462, "Palmitoylethanolamide for Chronic Inflammatory Pain Conditions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06273462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*